Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Towards theory integration: Threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory.

Hozo I, Djulbegovic B, Luan S, Tsalatsanis A, Gigerenzer G.

J Eval Clin Pract. 2015 Dec 18. doi: 10.1111/jep.12490. [Epub ahead of print]

PMID:
26683386
2.

Rationality, practice variation and person-centred health policy: a threshold hypothesis.

Djulbegovic B, Hamm RM, Mayrhofer T, Hozo I, Van den Ende J.

J Eval Clin Pract. 2015 Dec;21(6):1121-4. doi: 10.1111/jep.12486. Epub 2015 Dec 7.

PMID:
26639018
3.

Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular disease.

Djulbegovic B, Tsalatsanis A, Hozo I.

J Eval Clin Pract. 2015 Nov 11. doi: 10.1111/jep.12473. [Epub ahead of print]

PMID:
26555150
4.

Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.

Tsalatsanis A, Hozo I, Kumar A, Djulbegovic B.

PLoS One. 2015 Aug 5;10(8):e0134800. doi: 10.1371/journal.pone.0134800. eCollection 2015.

5.

Soluble P-selectin glycoprotein ligand - a possible new target in ulcerative colitis.

Ajdukovic J, Salamunic I, Hozo I, Despalatovic BR, Simunic M, Bonacin D, Puljiz Z, Trgo G, Sundov Z, Tonkic A.

Bratisl Lek Listy. 2015;116(3):147-9.

PMID:
25869560
6.

When is rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation.

Djulbegovic B, van den Ende J, Hamm RM, Mayrhofer T, Hozo I, Pauker SG; International Threshold Working Group (ITWG).

Eur J Clin Invest. 2015 May;45(5):485-93. doi: 10.1111/eci.12421. Epub 2015 Mar 9. Review.

PMID:
25675907
7.

Modern health care as a game theory problem: reply.

Djulbegovic B, Hozo I, Ioannidis J.

Eur J Clin Invest. 2015 Apr;45(4):443. doi: 10.1111/eci.12414. No abstract available.

PMID:
25630659
8.

Modern health care as a game theory problem.

Djulbegovic B, Hozo I, Ioannidis JP.

Eur J Clin Invest. 2015 Jan;45(1):1-12. doi: 10.1111/eci.12380. No abstract available.

PMID:
25413314
9.

Effect of initial conditions on reproducibility of scientific research.

Djulbegovic B, Hozo I.

Acta Inform Med. 2014 Jun;22(3):156-9. doi: 10.5455/aim.2014.22.156-159. Epub 2014 Jun 15.

10.

Uncertainty about effects is a key factor influencing institutional review boards' approval of clinical studies.

Wao H, Mhaskar R, Kumar A, Miladinovic B, Guterbock T, Hozo I, Djulbegovic B.

Ann Epidemiol. 2014 Oct;24(10):734-40. doi: 10.1016/j.annepidem.2014.06.100. Epub 2014 Jul 10. Erratum in: Ann Epidemiol. 2015 Feb;25(2):144.

PMID:
25108689
11.

When to perform hepatic resection for intermediate-stage hepatocellular carcinoma.

Cucchetti A, Djulbegovic B, Tsalatsanis A, Vitale A, Hozo I, Piscaglia F, Cescon M, Ercolani G, Tuci F, Cillo U, Pinna AD.

Hepatology. 2015 Mar;61(3):905-14. doi: 10.1002/hep.27321. Epub 2015 Jan 23.

PMID:
25048515
12.

Peptidoglycan recognition proteins kill bacteria by inducing oxidative, thiol, and metal stress.

Kashyap DR, Rompca A, Gaballa A, Helmann JD, Chan J, Chang CJ, Hozo I, Gupta D, Dziarski R.

PLoS Pathog. 2014 Jul 17;10(7):e1004280. doi: 10.1371/journal.ppat.1004280. eCollection 2014 Jul.

13.

How do physicians decide to treat: an empirical evaluation of the threshold model.

Djulbegovic B, Elqayam S, Reljic T, Hozo I, Miladinovic B, Tsalatsanis A, Kumar A, Beckstead J, Taylor S, Cannon-Bowers J.

BMC Med Inform Decis Mak. 2014 Jun 5;14:47. doi: 10.1186/1472-6947-14-47.

14.

Study design and the drug development process--reply.

Ioannidis JP, Hozo I, Djulbegovic B.

JAMA. 2014 May 21;311(19):2023-4. doi: 10.1001/jama.2014.3829. No abstract available.

PMID:
24846045
15.

Evaluation of Physicians' Cognitive Styles.

Djulbegovic B, Beckstead JW, Elqayam S, Reljic T, Hozo I, Kumar A, Cannon-Bowers J, Taylor S, Tsalatsanis A, Turner B, Paidas C.

Med Decis Making. 2014 Apr 10;34(5):627-637. [Epub ahead of print]

PMID:
24722474
16.

Improving the drug development process: more not less randomized trials.

Djulbegovic B, Hozo I, Ioannidis JP.

JAMA. 2014 Jan 22-29;311(4):355-6. doi: 10.1001/jama.2013.283742. No abstract available.

PMID:
24449311
17.

Preliminary report of hypoglycemic response in obese metabolic syndrome males treated with metformin after weight loss intervention.

Tesanović S, Radman M, Tesanović D, Erzen DJ, Hozo I.

Coll Antropol. 2013 Jun;37(2):367-71.

PMID:
23940976
18.

Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease.

Zulfiqar F, Hozo I, Rangarajan S, Mariuzza RA, Dziarski R, Gupta D.

PLoS One. 2013 Jun 19;8(6):e67393. Print 2013.

19.

Optimal type I and type II error pairs when the available sample size is fixed.

Ioannidis JP, Hozo I, Djulbegovic B.

J Clin Epidemiol. 2013 Aug;66(8):903-910.e2. doi: 10.1016/j.jclinepi.2013.03.002. Epub 2013 May 9.

PMID:
23664493
20.

Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.

Djulbegovic B, Kumar A, Miladinovic B, Reljic T, Galeb S, Mhaskar A, Mhaskar R, Hozo I, Tu D, Stanton HA, Booth CM, Meyer RM.

PLoS One. 2013;8(3):e58711. doi: 10.1371/journal.pone.0058711. Epub 2013 Mar 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk